Added to YB: 2025-06-04
Pitch date: 2025-06-03
TEVA [bullish]
Teva Pharmaceutical Industries Limited
+1.59%
current return
Author Info
Kontra Investment Xchange is trying to build wealth by investing in good companies and letting those investments compound over many years. Sign up for the newsletter.
Company Info
Teva Pharmaceutical Industries Limited develops, manufactures, markets, and distributes generic and other medicines, and biopharmaceutical products in the United States, Europe, Israel, and internationally.
Market Cap
$19.7B
Pitch Price
$61.08
Price Target
N/A
Dividend
N/A
Sector
Pharmaceuticals
Category
growth
Teva Pharmaceuticals ($TEVA): Pivoting to sustainable growth and long-term returns
TEVA: Pivot to Growth strategy to transform generics leader into balanced pharma co. Pipeline potential: UZEDY for schizophrenia, AUSTEDO expansion ($3B+ peak), duvakitug for IBD ($2-5B), emrusolmin for MSA ($2B+), DARI for asthma ($1B). Targets $5B innovative revenue by 2030, $3.5B FCF. Debt/EBITDA to 2.0x by 2027.
Read full article (4 min)